Green Circle Decarbonize Technology Limited Submits Tender Proposals for Chiller Replacement Engineering at MOS Centre and Air-Conditioning Retrofit & Operation and Maintenance at Nan Fung Centre in Hong Kong

The U.S. Commerce Department has taken equity stakes in 40 companies, including Intel (INTC), GlobalFoundries (GFS), and MP Materials (MP), as part of CHIPS Act research awards. Intel's stake is valued at $40.6B, while GlobalFoundries' is around $1.8B. MP Materials has a 10-year price floor agreement. Government ownership may reduce risk but also dilutes shares and limits upside.

SELLAS Life Sciences (SLS) shares dropped after the company announced its Phase 3 REGAL trial reached a key milestone, requiring a final analysis before a topline readout. The trial's progress is a critical development for investors.

RBC Capital kept its Sector Perform rating on Kinder Morgan with a $38 price target, suggesting a 12.3% upside from the Oct 27 close. The company reported a 5% Adjusted EBITDA beat in 3Q26 and increased its project backlog to $14.4 billion, indicating strong financial performance and growth prospects.

Genmab (GMAB) reported positive Phase 3 trial results for Petosemtamab combined with Keytruda in head and neck cancer, showing a 50% reduction in death risk and improved tumor response. The combination met primary endpoints and was well tolerated. GMAB plans regulatory discussions and further trials. The stock is up 28.89% at $57.53.

Boeing (BA) received a $499.76M contract modification for U.S. Army's AH-64 Apache program, with work continuing through 2031. Details on work locations and funding are to be determined. The contract covers engineering and technical support services.

Pfizer has temporarily closed a cancer drug manufacturing site in India, which may worsen drug shortages. The facility will remain shut for up to two years, according to the company.